Axcelis Technologies (NASDAQ:ACLS) has built an enviable niche in the semiconductor capital equipment market, but recent cyclical headwinds present an intriguing opportunity for value-oriented growth investors. Despite navigating a semiconductor digestion phase that pulled annual revenue down to $839 million in 2025, the company’s underlying structural thesis remains robust. Axcelis maintains a pristine balance sheet […]
Axcelis Technologies (NASDAQ:ACLS) has outperformed the market over the past 15 years by 10.06% on an annualized basis producing an average annual return of 23.67%. Currently, Axcelis Technologies has a market
Axcelis Technologies has announced plans to invest US$35,000,000 in a new 200,000-square-foot ion implantation equipment manufacturing facility in Pyeongtaek, Korea, with integrated cleanrooms, warehousing, and training capabilities, following an investment declaration ceremony with Korean government bodies and production targeted to start in the second half of 2028. This expansion adds a significant Asian manufacturing hub that could enhance Axcelis’s ability to respond quickly to customer...
Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) taking place September 28 - October 2, 2026, at the Pacifico Yokohama North in Japan.
Axcelis Technologies (ACLS) concluded the recent trading session at $103.75, signifying a -1.23% move from its prior day's close.
Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the International Conference on Ion Implantation and Annealing Technology 2026 (IIT 2026) taking place September 20-24 at the Congress Center Villach in Austria. IIT 2026 is the 25th Conference in the biennial series focused on the major challenges in current and emerging technologies related to implant/doping and annealing processes,
Axcelis Technologies (ACLS) closed the most recent trading day at $115.56, moving 3.03% from the previous trading session.
Axcelis-Veeco $4.4B stock merger: $1.6–$1.7B sales, $35M synergies, but weak ops and capped earnings. Click to read this analysis of ACLS & VECO stocks.
Why Axcelis Technologies Is Back On Investor Radars Axcelis Technologies (ACLS) recently announced plans to join upcoming investor conferences, including the Citi 2026 Global TMT Conference and the B. Riley Securities Consumer & TMT Conference, which has put fresh attention on the stock. The recent conference announcements come after a mixed price pattern for Axcelis Technologies, with the share price up 28.62% year to date but down 31.57% over 90 days. The 1-year total shareholder return of...
Axcelis Technologies has delivered a strong 5 year share price gain, yet the stock now screens as expensive on several valuation checks and carries a low overall value score. For investors, the recent pullback raises the question of whether this is a healthy reset or a sign that earlier enthusiasm pushed the valuation too far. Axcelis Technologies has returned about 127% over 5 years, which points to a stock that has already rewarded patient holders. The company’s ability to convert its...
Investors need to pay close attention to ACLS stock based on the movements in the options market lately.
Motley Fool Press Release.
Detailed price information for Axcelis Tech Inc (ACLS-Q) from The Globe and Mail including charting and trades.
Detailed price information for Twilio (TWLO-N) from The Globe and Mail including charting and trades.
Detailed price information for Leidos Holdings Inc (LDOS-N) from The Globe and Mail including charting and trades.
Axcelis Technologies (ACLS) has an average rating of hold and mean price target of $161, according t
The company raised its 2026 guidance to mid single-digit growth, driven by robust bookings, a strong CSI business, and expanding opportunities in advanced logic and memory.
Axcelis Technologies (ACLS) shares were 1.1% higher in Thursday trading after the company reported Q
Axcelis Technologies (NASDAQ:ACLS) reported second-quarter 2026 revenue of $215 million and non-GAAP diluted earnings per share of $1.06, with both figures exceeding management’s expectations. The company raised its outlook for the full year, now expecting mid-single-digit revenue growth after previ
Axcelis (ACLS) delivered earnings and revenue surprises of +17.78% and +4.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the second quarter ended June 30, 2026.
System qualified for emerging PMIC device application requiring advanced 15 MeV implant capability
Axcelis Technologies has delivered a strong 207.1% return over the past 5 years, yet the latest valuation checks suggest the stock now leans expensive on market multiples and only scores middling on overall value tests. After sharp recent share price declines, investors are weighing that long term gain against a mixed read on value. Over 5 years the stock is up 207.1%, which puts long term holders in a strong position even after the recent pullback. The successful evaluation closure of the...
In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $134.1, denoting a -5.24% move from the preceding trading day.
BEVERLY, Mass. , July 22, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter of 2026 bef...
In the most recent trading session, Axcelis Technologies (ACLS) closed at $145.01, indicating a +1.95% shift from the previous trading day.
This is the newest page. Registered accounts read further back.